These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 10330297)
1. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects. Semana G; Gausling R; Jackson RA; Hafler DA J Autoimmun; 1999 Jun; 12(4):259-67. PubMed ID: 10330297 [TBL] [Abstract][Full Text] [Related]
2. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes. Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644 [TBL] [Abstract][Full Text] [Related]
3. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes. Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713 [TBL] [Abstract][Full Text] [Related]
4. Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens. Shigematsu H; Shimoda S; Nakamura M; Matsushita S; Nishimura Y; Sakamoto N; Ichiki Y; Niho Y; Gershwin ME; Ishibashi H Hepatology; 2000 Nov; 32(5):901-9. PubMed ID: 11050037 [TBL] [Abstract][Full Text] [Related]
5. A proinsulin 74-90-derived protease-resistant, altered peptide ligand increases TGF-beta 1 secretion in PBMC from patients with type 1 diabetes mellitus. van Aalst D; Kalbacher H; Palesch D; Zou F; Spyrantis A; Rosinger S; Boehm BO; Burster T J Leukoc Biol; 2010 May; 87(5):943-8. PubMed ID: 20110445 [TBL] [Abstract][Full Text] [Related]
6. T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. Lohmann T; Leslie RD; Londei M J Autoimmun; 1996 Jun; 9(3):385-9. PubMed ID: 8816975 [TBL] [Abstract][Full Text] [Related]
7. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. Abulafia-Lapid R; Elias D; Raz I; Keren-Zur Y; Atlan H; Cohen IR J Autoimmun; 1999 Mar; 12(2):121-9. PubMed ID: 10047432 [TBL] [Abstract][Full Text] [Related]
8. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity. Durinovic-Belló I; Boehm BO; Ziegler AG J Autoimmun; 2002 Feb; 18(1):55-66. PubMed ID: 11869047 [TBL] [Abstract][Full Text] [Related]
9. Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes. Vadacca M; Valorani MG; von Hofe E; Kallinteris NL; Buzzetti R; Pozzilli P Horm Metab Res; 2011 Jun; 43(7):483-8. PubMed ID: 21512962 [TBL] [Abstract][Full Text] [Related]
10. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. Roep BO; Atkinson MA; van Endert PM; Gottlieb PA; Wilson SB; Sachs JA J Autoimmun; 1999 Sep; 13(2):267-82. PubMed ID: 10479395 [TBL] [Abstract][Full Text] [Related]
11. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Rudy G; Stone N; Harrison LC; Colman PG; McNair P; Brusic V; French MB; Honeyman MC; Tait B; Lew AM Mol Med; 1995 Sep; 1(6):625-33. PubMed ID: 8529129 [TBL] [Abstract][Full Text] [Related]
12. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. Naquet P; Ellis J; Tibensky D; Kenshole A; Singh B; Hodges R; Delovitch TL J Immunol; 1988 Apr; 140(8):2569-78. PubMed ID: 2451692 [TBL] [Abstract][Full Text] [Related]
13. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333 [TBL] [Abstract][Full Text] [Related]
14. GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. Oling V; Marttila J; Ilonen J; Kwok WW; Nepom G; Knip M; Simell O; Reijonen H J Autoimmun; 2005 Nov; 25(3):235-43. PubMed ID: 16263242 [TBL] [Abstract][Full Text] [Related]
15. HLA class I epitope discovery in type 1 diabetes. van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554 [TBL] [Abstract][Full Text] [Related]
16. Persistent T cell anergy in human type 1 diabetes. Dosch H; Cheung RK; Karges W; Pietropaolo M; Becker DJ J Immunol; 1999 Dec; 163(12):6933-40. PubMed ID: 10586096 [TBL] [Abstract][Full Text] [Related]
17. Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin. Griffin AC; Zhao W; Wegmann KW; Hickley WF Am J Pathol; 1995 Sep; 147(3):845-57. PubMed ID: 7545875 [TBL] [Abstract][Full Text] [Related]
18. T cell activation and anergy to islet cell antigen in type I diabetes. Miyazaki I; Cheung RK; Gaedigk R; Hui MF; Van der Meulen J; Rajotte RV; Dosch HM J Immunol; 1995 Feb; 154(3):1461-9. PubMed ID: 7822811 [TBL] [Abstract][Full Text] [Related]
19. Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls. Ott PA; Herzog BA; Quast S; Hofstetter HH; Boehm BO; Tary-Lehmann M; Durinovic-Bello I; Berner BR; Lehmann PV Clin Immunol; 2005 Apr; 115(1):102-14. PubMed ID: 15870028 [TBL] [Abstract][Full Text] [Related]
20. Dendritic cell-based assays, but not mannosylation of antigen, improves detection of T-cell responses to proinsulin in type 1 diabetes. Narendran P; Elsegood K; Leech NJ; Macindoe WM; Boons GJ; Dayan CM Immunology; 2004 Apr; 111(4):422-9. PubMed ID: 15056379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]